Daniel H Doherty

This inventor holds 27 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Bolder Biotechnology, Inc., Amgen Inc., Dsm IP Assets B.v.. Active years: 1996-2015.

USPTO Granted Patents = 27 (Patent Applications = 3)

% Patents Active = 63.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 3.4

ph-index = 11

Forward Citations = 514(Granted Patents)

Company Filing History:

9 out of 45

Bolder Biotechnology, Inc.

Getty Scientific Development Company

Seikagaku Corporation

patents

7. 1 out of 13

Baxter Biotech Technology Sarl

Martek Biosciences Corporation

patents

10. 1 out of 659

William Marsh Rice University

patents

11. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2015

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9175293 - Compositions and methods for bacterial and genetically modified microorganism production of chondroitin (2015-11-03),

2. 8932828 - Method for preparing recombinant granulocyte colony stimulating factor cysteine muteins (2015-01-13),

3. 8859855 - Chimeric PUFA polyketide synthase systems and uses thereof (2014-10-14),

4. 8697398 - Compositions and methods for bacterial production of chondroitin (2014-04-15),

5. 8309796 - Chimeric PUFA polyketide synthase systems and uses thereof (2012-11-13),

6. 8288126 - Methods for making proteins containing free cysteine residues (2012-10-16),

7. 8148500 - Method of preparing cysteine mutants of human recombinant GM-CSF (2012-04-03),

8. 8003772 - Chimeric PUFA polyketide synthase systems and uses thereof (2011-08-23),

9. 7947655 - Methods for making proteins containing free cysteine residues (2011-05-24),

10. 7824669 - In vivo stimulation of peripheral blood progenitor cells by granulocyte-macrophage colony stimulating factor (GM-CSF) cysteine muteins and their PEGylated variants (2010-11-02),

11. 7754855 - Immunoglobulin fusion proteins (2010-07-13),

12. 7306931 - Method for refolding proteins containing free cysteine residues (2007-12-11),

13. 7226758 - Nucleic acids encoding glial cell line-derived neurotrophic factor (GDNF) (2007-06-05),

14. 7153943 - Derivatives of growth hormone and related proteins, and methods of use thereof (2006-12-26),

15. 7049406 - Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging (2006-05-23),

Title: The Inventor Profile of Daniel H. Doherty

Introduction: Daniel H. Doherty is a renowned inventor based in Boulder, Colorado, known for his groundbreaking contributions to various technological fields.

Latest Patents: Daniel H. Doherty holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his innovative spirit and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Daniel H. Doherty has worked with leading research institutions and tech companies, playing a key role in developing cutting-edge technologies that have revolutionized the industry.

Collaborations: Throughout his career, Daniel H. Doherty has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and creativity that has led to the successful implementation of numerous projects.

Conclusion: Daniel H. Doherty's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology, with his work continuing to inspire future generations of inventors.